FBRX

Conviction 80HealthcareScan · Thu, Sep 24, 2026

Forte Biosciences Inc (FBRX) closed at $76.99 (+0.03%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 84, RS Rating 99, at a 52-week high, +226.1% year to date. Sector: Healthcare · Biotechnology.

FBRX$76.99+0.03%

ResistanceSupportVol 14

Vol MA14 1.68M

May 28Jun 15Jul 6Jul 22Aug 10Aug 26

Forte Biosciences IncBiotechnologywww.fortebiorx.com ↗

Price76.99

Change+0.03%

Gap+0.00%

Rel volume0.75×

Avg volume1.57M

Avg $ vol120.74M

SMA 2076.83

SMA 5052.74

SMA 20032.21

Price vs 50+45.99%

Price vs 200+138.99%

MA stackbullish

50/200 cross—

Supertrendup · 74.67

RSI (14)84

MACD hist-1.75

MACD cross—

Stoch %K / %D96 / 97

ADX (14)84

+DI / −DI49 / 3

RSI divergence—

MACD divergence—

ATR %1.62%

ADR %0.17%

52w high76.99

52w low10.30

From 52w high+0.00%

Above 52w low+647.48%

New 52w highYes

SqueezeOff

Bollinger width0.67%

%B0.82

Donchian pos70.00%

Donchian high77.20

Donchian low76.50

AVWAP (52w high)76.85

vs AVWAP high+0.18%

AVWAP (52w low)52.16

vs AVWAP low+47.61%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d0.75×

Avg vol (14d)1.68M

Avg vol (20d)1.57M

Avg $ vol (20d)120.74M

Market cap359.61M

RS Rating99 / 99

RS 3m (vs SPY)+256.51%

RS 6m (vs SPY)+160.19%

RS line new highNo

Trend template8/8

Technical rank94.5

1 week+0.12%

1 month+0.44%

3 months+258.59%

6 months+170.71%

1 year+580.42%

YTD+226.09%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeXNAS

Shares out20.48M

Employees22

ListedTue, Jun 16, 2020

Free float7.51M

Float %60.0%

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank94.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance77.02

Support30.34

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in FBRX

All disclosures →

No recent disclosed trades by Congress in FBRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FBRX

Insider	Side	Shares	Value	Traded	Filed
Kornfeld Steven Director · Restricted Stock Units · 2026-08-27	Disposition	18.35K	—	2026-08-27	2026-08-27
Brun Scott C. Director · Stock Option (right to buy) · 2026-08-27	Disposition	2K	—	2026-08-27	2026-08-27
Brun Scott C. Director · Stock Option (right to buy) · 2026-08-27	Disposition	1K	—	2026-08-27	2026-08-27
Brun Scott C. Director · Stock Option (right to buy) · 2026-08-27	Disposition	31K	—	2026-08-27	2026-08-27
Brun Scott C. Director · Restricted Stock Units · 2026-08-27	Disposition	18.35K	—	2026-08-27	2026-08-27
Doberstein Stephen K Director · Stock Option (right to buy) · 2026-08-27	Disposition	2K	—	2026-08-27	2026-08-27
Doberstein Stephen K Director · Stock Option (right to buy) · 2026-08-27	Disposition	1K	—	2026-08-27	2026-08-27
Doberstein Stephen K Director · Stock Option (right to buy) · 2026-08-27	Disposition	31K	—	2026-08-27	2026-08-27
Doberstein Stephen K Director · Restricted Stock Units · 2026-08-27	Disposition	18.35K	—	2026-08-27	2026-08-27
FINCK BARBARA K Director · Stock Option (right to buy) · 2026-08-27	Disposition	2K	—	2026-08-27	2026-08-27

SEC filings

EDGAR filings in FBRX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.